How 3 health systems are scaling home-based models

The latest stories trending on MedCity News.

The newsletter will be paused from 11/28-11/30 for the upcoming holiday and publish as usual from 12/2. Happy Thanksgiving!

Editor's Pick

Top Story How 3 Health Systems Are Scaling Hybrid & Home-Based Models Leaders from three health systems — Providence, OSF HealthCare and UMass Memorial Health — detailed how their organizations are maximizing hybrid and home-based care models during a recent panel. Sponsored Could GLP-1 Drugs Be Included In Health Coverage? Presented by Personify Health In this new episode of the MedCity Pivot Podcast, Chief Medical Officer Jeff Jacques offers a window into companies' strategies for including GLP-1 drugs in their health benefits. Get The Full Episode Here

Featured News

Weight Loss With Amgen Drug in Line With Eli Lilly Med, But Dosing Could Be Differentiator Amgen's experimental obesity drug, MariTide, led to an average 20% reduction in weight in a Phase 2 clinical trial. While investors hoped for greater weight loss, some analysts say less burdensome monthly dosing of MariTide could make it competitive against weekly injectable weight drugs Zepbound and Wegovy. MedCity FemFwd: How Celmatix is Using ARPA-H's Sprint for Women's Health Funding In this episode, we're joined by Dr. Piraye Yurttas Beim, founder and CEO of Celmatix, a women's health biotech company. She discusses the funding the company recently received through the Sprint for Women's Health program. HRSA Commits $52M to Health Centers Supporting People Leaving Incarceration The Health Resources and Services Administration is making a $52 million investment in 54 health centers to support the health needs of those leaving incarceration. Roche Expands Its Scope in Allogeneic Cell Therapy With $1B Poseida Therapeutics Acquisition Roche is acquiring Poseida Therapeutics, a biotech developing allogeneic cell therapies for cancers and immunological indications. The two companies have been partners in hematological malignancies since 2022. The Promise and Challenge of GLP-1 Medications: Ensuring ROI in Obesity Care Pricy GLP-1 medications are here to stay — let's focus on turning their potential into lasting, meaningful impact. AI-Powered Insights for Personalized Customer Experiences: The Art of Data-Driven Engagement While advanced analytics and AI can unlock unprecedented insights, it's the thoughtful application of these insights that transforms routine interactions between pharmaceutical representatives and healthcare providers into lasting relationships.

Resources

MedCity FemFwd: How Doulas Can Improve Maternal Health Outcomes In this episode, we're joined by Dr. Tiffany Inglis, national medical director for women and children's health at Carelon Health, a subsidiary of Elevance Health. Inglis discusses a paper Elevance Health Public Policy Institute recently published about doulas. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe